Steven Haken

Odelle Technology is a specialist consultancy focused on medical technology reimbursement, health economics, and market access across the UK and EU. With experience across 2,000+ cases, we help digital health, IVD, biotech, and surgical innovators secure adoption through rigorous evidence, real-world data, and payer alignment. Our services span four domains: Reimbursement Strategy – We secure inpatient/outpatient codes (HRG, DRG, OPS), digital health access (e.g. DiGA, PECAN), IVD inclusion (e.g. LPPR, EBM), and private insurer coverage (e.g. CCSD). Health Economic Modelling – We build cost-consequence models, budget impact analyses (BIA), and pathway-adjusted CEAs in line with NICE, HAS, IQWiG, ZIN, and TLV methods. Evidence & HTA – We structure submissions for national HTA agencies, NICE HealthTech Connect, LPPR dossiers, and economic evidence packages for ZIN, RIZIV/INAMI, and KCE. Stakeholder Engagement – We work with ICBs, CFOs, guideline groups, and patient organisations to convert pilot studies into reimbursed pathways. We cover all EU5 countries, the UK, Benelux, Nordics, and support public-private consortia, investors, and NHS Trusts. Special areas: ✓ Rapid diagnostics & IVDs (e.g. AST, biomarker panels) ✓ Digital health apps & AI platforms ✓ High-cost surgical and implantable devices ✓ Companion diagnostics & rare disease tools We align with NHS Long Term Plan, GIRFT, PECAN, CDC, and national digital transformation policies. Odelle turns scientific validation into financial adoption. We translate clinical value into contracts, models into money, and pilots into national programs. 📍 www.odelletechnology.com 📧 steven@odelletechnology.com | 📞 +44 (0)7804 623 339